Small Diagnostic Chains

Thyrocare Technologies Ltd.

THYROCARE

Market Cap
₹8,394 Cr.
P/E
51.37

Thyrocare Technologies Ltd.

  • Thyrocare Tech.
  • Metropolis Health.
  • Vijaya Diagnostic
  • TJI Diagnostic Chains

FAQs on Thyrocare Technologies Ltd. Shareprice

Thyrocare Tech. has given better returns compared to its competitors.
Thyrocare Tech. has grown at ~25.64% over the last 4yrs while peers have grown at a median rate of 12.98%

Yes, Thyrocare Tech. is expensive.
Latest PE of Thyrocare Tech. is 51.37, while 3 year average PE is 44.75.
Also latest EV/EBITDA of Thyrocare Tech. is 31.77 while 3yr average is 25.2.

View FAQ's On Business

Growth Table

  • Thyrocare Technologies Ltd.
  • Metropolis Health.
  • Vijaya Diagnostic

Balance Sheet

  • Thyrocare Technologies Ltd.
  • Metropolis Health.
  • Vijaya Diagnostic

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Thyrocare Technologies Ltd.
  • Metropolis Health.
  • Vijaya Diagnostic

Cash Flow

  • Thyrocare Technologies Ltd.
  • Metropolis Health.
  • Vijaya Diagnostic

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Thyrocare Technologies Ltd.
  • Metropolis Health.
  • Vijaya Diagnostic

Quarterly Results

  • Thyrocare Technologies Ltd.
  • Metropolis Health.
  • Vijaya Diagnostic

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Thyrocare Technologies Ltd. Financials

Balance sheet of Thyrocare Tech. is strong.
It shouldn't have solvency or liquidity issues.

The net debt of Thyrocare Tech. is decreasing.
Latest net debt of Thyrocare Tech. is -₹136.1 Crs as of Mar-26.
This is less than Mar-25 when it was -₹108.8 Crs.

Yes, profit is increasing.
The profit of Thyrocare Tech. is ₹163 Crs for Mar 2026, ₹90.74 Crs for Mar 2025 and ₹71.05 Crs for Mar 2024

The company seems to pay a good stable dividend.
Thyrocare Tech. latest dividend payout ratio is 136.36% and 3yr average dividend payout ratio is 131.05%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Cash & Short Term Investments

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech